NICE Stock Analysis: Nice | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 5.542m USD | 12M Return: -42.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 60.9M
EPS Trend: 97.4%
Qual. Beats: 1
Rev. Trend: 99.3%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
NICE Ltd. is an Israel-based software company listed on NASDAQ that provides AI-powered cloud platforms across two main segments: Customer Engagement and Financial Crime and Compliance. The Customer Engagement segment is built around its CXone Mpower platform, which helps organizations automate service operations, deploy AI-assisted workforce tools, and unify enterprise knowledge and customer experience workflows. The Financial Crime and Compliance segment delivers embedded-AI solutions for anti-money laundering (AML), fraud prevention, know-your-customer (KYC) processes, and real-time capital markets compliance, with product lines such as NiCE Actimize, X-Sight, and Xceed targeted at institutions of varying sizes.
In addition to its core financial services offerings, the company provides NICE Evidencentral, a digital evidence management platform used in the criminal justice system, and runs NiCE Labs as an internal innovation initiative focused on customer experience technologies. Founded in 1986 and headquartered in Raanana, Israel, NICE operates globally across the United States, Europe, the Middle East, Africa, and Asia Pacific. It is classified within the GICS Information Technology sector and Application Software sub-industry, competing in the enterprise software and regtech/fintech space where recurring SaaS revenue and regulatory demand for compliance tools are key industry characteristics.
- CXone Mpower cloud ARR growth accelerates recurring mix
- Financial Crime and Compliance demand rises on fraud and AML spending
- Competition from Verint and CCaaS peers pressures pricing and margins
| Net Income: 529.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -4.12 > 1.0 |
| NWC/Revenue: 7.93% < 20% (prev 33.16%; Δ -25.23% < -1%) |
| CFO/TA 0.12 > 3% & CFO 610.2m > Net Income 529.5m |
| Net Debt (-224.2m) to EBITDA (902.9m): -0.25 < 3 |
| Current Ratio: 1.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (60.6m) vs 12m ago -5.85% < -2% |
| Gross Margin: 65.79% > 18% (prev 66.90%; Δ -1.11% > 0.5%) |
| Asset Turnover: 58.97% > 50% (prev 53.06%; Δ 5.91% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.05 (Total Current Assets 1.30b - Total Current Liabilities 1.06b) / Total Assets 4.98b |
| B: 0.67 (Retained Earnings 3.31b / Total Assets 4.98b) |
| C: 0.13 (EBIT TTM 685.7m / Avg Total Assets 5.11b) |
| D: 2.81 (Book Value of Equity 3.68b / Total Liabilities 1.31b) |
| Altman-Z'' = 6.34 = AAA |
| DSRI: 1.10 (Receivables 767.3m/643.2m, Revenue 3.01b/2.78b) |
| GMI: 1.02 (GM 66.90% / 65.79%) |
| AQI: 1.43 (AQ_t 0.68 / AQ_t-1 0.48) |
| SGI: 1.08 (Revenue 3.01b / 2.78b) |
| TATA: -0.02 (NI 529.5m - CFO 610.2m) / TA 4.98b) |
| Beneish M = -2.62 (Cap -4..+1) = A |
As of July 06, 2026, the stock is trading at USD 96.74 with a total of 413,400 shares traded. Over the past week, the price has changed by +10.43%, over one month by +3.87%, over three months by -14.67% and over the past year by -42.93%.
Current recommended Stop Loss: 91.80 (which is 5.1% or 1.2 ATR below the current price).
Nice has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy NICE.
- StrongBuy: 10
- Buy: 4
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 131.4 | 35.9% |
P/E Trailing = 11.2491
P/E Forward = 8.5616
P/S = 1.8389
P/B = 1.5115
P/EG = 0.5706
Revenue TTM = 3.01b USD
EBIT TTM = 685.7m USD
EBITDA TTM = 902.9m USD
Long Term Debt = 72.5m USD (estimated: total debt 86.1m - short term 13.6m)
Short Term Debt = 13.6m USD (from shortTermDebt, last quarter)
Debt = 86.1m USD (from shortLongTermDebtTotal, last quarter) (leases 86.1m already included)
Net Debt = -224.2m USD (calculated: Debt 86.1m - CCE 310.2m)
Enterprise Value = 5.32b USD (5.54b + Debt 86.1m - CCE 310.2m)
Interest Coverage Ratio = unknown (Ebit TTM 685.7m / Interest Expense TTM 0.0)
EV/FCF = 10.08x (Enterprise Value 5.32b / FCF TTM 527.6m)
FCF Yield = 9.92% (FCF TTM 527.6m / Enterprise Value 5.32b)
FCF Margin = 17.52% (FCF TTM 527.6m / Revenue TTM 3.01b)
Net Margin = 17.58% (Net Income TTM 529.5m / Revenue TTM 3.01b)
Gross Margin = 65.79% ((Revenue TTM 3.01b - Cost of Revenue TTM 1.03b) / Revenue TTM)
Gross Margin QoQ = 64.38% (prev 65.33%)
Tobins Q-Ratio = 1.07 (Enterprise Value 5.32b / Total Assets 4.98b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 86.1m)
Taxrate = 22.78% (156.2m / 685.7m)
NOPAT = 529.5m (EBIT 685.7m * (1 - 22.78%))
Current Ratio = 1.22 (Total Current Assets 1.30b / Total Current Liabilities 1.06b)
Debt / Equity = 0.02 (Debt 86.1m / totalStockholderEquity, last quarter 3.68b)
Debt / EBITDA = -0.25 (Net Debt -224.2m / EBITDA 902.9m)
Debt / FCF = -0.42 (Net Debt -224.2m / FCF TTM 527.6m)
Total Stockholder Equity = 3.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.37% (Net Income 529.5m / Total Assets 4.98b)
RoE = 13.98% (Net Income TTM 529.5m / Total Stockholder Equity 3.79b)
RoCE = 17.77% (EBIT 685.7m / Capital Employed (Equity 3.79b + L.T.Debt 72.5m))
RoIC = 14.00% (NOPAT 529.5m / Invested Capital 3.78b)
WACC = 9.93% (E(5.54b)/V(5.63b) * Re(10.08%) + D(86.1m)/V(5.63b) * Rd(0.0%) * (1-Tc(0.23)))
Discount Rate = 10.08% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.11 | Cagr: -3.56%
[DCF] Terminal Value 67.44% ; FCFF base≈624.3m ; Y1≈547.5m ; Y5≈442.4m
[DCF] Fair Price = 100.4 (EV 5.64b - Net Debt -224.2m = Equity 5.86b / Shares 58.4m; r=9.93% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 97.38 | EPS CAGR: 15.69% | SUE: 1.86 | # QB: 1
Revenue Correlation: 99.33 | Revenue CAGR: 11.15% | SUE: 1.36 | # QB: 2
EPS current Quarter (2026-06-30): EPS=2.64 | Chg30d=+0.00% | Revisions=+39% | Analysts=15
EPS next Quarter (2026-09-30): EPS=2.79 | Chg30d=+0.00% | Revisions=-6% | Analysts=14
EPS current Year (2026-12-31): EPS=11.09 | Chg30d=+0.00% | Revisions=+84% | GrowthEPS=-9.8% | GrowthRev=+7.9%
EPS next Year (2027-12-31): EPS=12.63 | Chg30d=+0.00% | Revisions=+42% | GrowthEPS=+13.8% | GrowthRev=+9.7%
[Analyst] Revisions Ratio: +48% (up=45, down=15)